CMND
insider transactionsClearmind Medicine Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
+1.9M
2.2M buy · 252.6K sell
Net value · 365d
$211.8K
$330.3K in · $118.5K out
Sentiment · 365d
Net buying
74% buying · 26% selling
Open-market trades · 365d
5
2.2M buy · 252.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
10% Owner
$73.2K
22.1K sh · $3.31
Own -21%
-
Sell·S
10% Owner
$10.6K
3.2K sh · $3.32
Own -3%
-
Sell·S
10% Owner
$7.1K
2.1K sh · $3.36
Own -2%
-
Sell·S
10% Owner
$27.7K
225.2K sh · $0.12
Own -11%
-
Buy·P
10% Owner
$330.3K
2.2M sh · $0.15
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | HRT FINANCIAL LP | Sell S | 22.1K | $73.2K |
| Jun 15, 2026 | HRT FINANCIAL LP | Sell S | 3.2K | $10.6K |
| Jun 12, 2026 | HRT FINANCIAL LP | Sell S | 2.1K | $7.1K |
| Jun 11, 2026 | HRT FINANCIAL LP | Sell S | 225.2K | $27.7K |
| Jun 10, 2026 | HRT FINANCIAL LP | Buy P | 2.2M | $330.3K |
About CMND insider trading
This page tracks insider transactions for Clearmind Medicine Inc. (CMND) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.